Fibroheal Woundcare, a promising Silk proteins-based medical devices startup has raised Rs 6.3 crore in its pre-Series A round. The funding round was led by its existing promoters and new investors which included surgeons, medical professionals, and bankers.
Furthermore, the company also has an additional commitment of another Rs 10 crore from existing as well as some new investors. This funding will be utilized to ramp up its go-to-market strategy while focusing on recruiting more people, and investing in its product pipeline pertaining to the medical devices segment.
The company was established by Vivek Mishra and Bharat Tandon back in 2027, wherein, Fibroheal’s products are currently being used in more than 500 hospitals across India while enjoying its presence over 19 states. Also, the company has also branched out to selling its products across various e-commerce platforms.
The company’s product line such as foams, mesh, and powders, among others, is being utilized to heal different types of acute, chronic, traumatic, post-operative, non-healing, or difficult-to-heal wounds such as bed sores or infected C-section wounds, among others. Previously, Fibroheal has successfully raised funds from existing promoters Telama Investments, CCAMP and KITVEN.
